February 20, 2009

Nine out of every 10 new patients have injuries related to bomb explosions?primarily fractures and wounds.

February 19, 2009

MSF is preparing to scale up its assistance to displaced people in camps in and around the city of Vavuniya, in Northern Province, Sri Lanka. MSF is already distributing food and basic relief items in 10 camps and plans to work in five more.

February 17, 2009

An MSF team has returned to Muhajariya in South Darfur where an estimated 35,000 people have been affected by heavy fighting. The team had been forced to leave for four weeks.

February 17, 2009

Dealing with cholera is different than other emergencies I have worked on. It was the speed of it that made it so different. When you enter an area with many people sick from cholera or a clinic completely overloaded with cholera patients, you know lives will soon be lost.

February 17, 2009

I was awakened in the night by a phone call from a nurse on night duty who had been told that four children were seen along the road too sick to continue their walk to the nearest CTU.

February 17, 2009

The widespread cholera outbreak continues throughout Zimbabwe. As previously reported, the focus of the outbreak has shifted from urban to rural areas, but cities are still a concern.

February 15, 2009

MSF welcomes recognition by UK drugs company GlaxoSmithKline that patents act as a barrier to research and development and that patent pools offer new ways to stimulate research into neglected diseases. Promises now need to be turned into action.

February 12, 2009

MSF provides mental health counseling in Vavuniya for traumatized patients.

February 12, 2009

MSF has mobilized significant human and logistical resources to fight an ongoing measles epidemic in the district of Abéché, Chad.

February 10, 2009

After attempting for almost two years to reach an agreement with China’s tuberculosis (TB) control program, MSF has given up on its efforts to start a project in Inner-Mongolia for assisting people suffering from multi-drug resistant tuberculosis (MDR-TB).